Mouse models of inherited cancer syndromes.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Hematology/Oncology Clinics of North America

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.hoc.2010.08.011PMID 21075289PMCID PMC3011940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.

  2010cited by this paper
• Preclinical mouse models for BRCA1-associated breast cancer

  2009cited by this paper
• Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer.

  2009cited by this paper
• Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia

  2009cited by this paper
• Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation

  2009cited by this paper
• Birt-Hogg-Dubé syndrome: diagnosis and management.

  2009cited by this paper
• Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2

  2009cited by this paper
• Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations

  2009cited by this paper
• DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?

  2009cited by this paper
• Colitis and cancer: a tale of inflammatory cells and their cytokines.

  2008cited by this paper
• Novel Roles for MLH3 Deficiency and TLE6-Like Amplification in DNA Mismatch Repair-Deficient Gastrointestinal Tumorigenesis and Progression

  2008cited by this paper
• Peutz-Jeghers syndrome

  2008cited by this paper
• Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

  2008cited by this paper
• Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

  2008cited by this paper
• Principles and practice of gastrointestinal oncology

  2008cited by this paper
• Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza™, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer

  2008cited by this paper
• Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones

  2008cited by this paper
• Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis

  2008cited by this paper
• Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.

  2008cited by this paper
• Apc mice: models, modifiers and mutants.

  2008cited by this paper
• BRCA1, Hormone, and Tissue-Specific Tumor Suppression

  2008cited by this paper
• The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression

  2008cited by this paper
• Tractable Cre-lox system for stochastic alteration of genes in mice

  2008cited by this paper
• Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

  2007cited by this paper
• Maximizing mouse cancer models

  2007cited by this paper
• Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer

  2007cited by this paper
• Discovery and development of SAHA as an anticancer agent

  2007cited by this paper
• Thompson & Thompson Genetics in Medicine

  2007cited by this paper
• Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

  2007cited by this paper
• A mouse model of basal‐like breast carcinoma with metaplastic elements

  2007cited by this paper
• The first knockout mouse model of retinoblastoma.

  2006cited by this paper
• Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist

  2006cited by this paper
• Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects

  2006cited by this paper
• Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

  2006cited by this paper
• The Incidence of Lynch Syndrome

  2005cited by this paper
• A Mouse Model of Activating Met Mutations

  2005cited by this paper
• Mismatch Repair and Tumor Suppression in the Mouse to DNA Pms 2 and Mlh 3 Contributions by MutL Homologues

  2005cited by this paper
• A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.

  2005cited by this paper
• The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency

  2005cited by this paper
• Brca2 Deficiency Does Not Impair Mammary Epithelium Development but Promotes Mammary Adenocarcinoma Formation in p53+/− Mutant Mice

  2004cited by this paper
• An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis

  2004cited by this paper
• Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

  2004cited by this paper
• Mutations Associated with HNPCC Predisposition — Update of ICG-HNPCC/INSiGHT Mutation Database

  2004cited by this paper
• Loss of DNA mismatch repair function and cancer predisposition in the mouse: Animal models for human hereditary nonpolyposis colorectal cancer

  2004cited by this paper
• Frontiers of mutagenesis and DNA repair: a workshop.

  2004cited by this paper
• A Mouse Model for Carney Complex

  2004cited by this paper
• Lynch Syndrome Genes

  2004cited by this paper
• The Incidence of Lynch Syndrome

  2004cited by this paper
• Mouse Models of Human Familial Cancer Syndromes

  2004cited by this paper
• Of Mice and MEN1: Insulinomas in a Conditional Mouse Knockout

  2003cited by this paper
• Studying cancer families to identify kidney cancer genes.

  2003cited by this paper
• Hereditary renal cancers.

  2003cited by this paper
• Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

  2003cited by this paper
• Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model.

  2003cited by this paper
• Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice.

  2003cited by this paper
• Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation.

  2003cited by this paper
• Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice.

  2002cited by this paper
• The Molecular and Genetic Basis of Neurological Tumours

  2002cited by this paper
• Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer

  2002cited by this paper
• The retinoblastoma tumour suppressor in development and cancer

  2002cited by this paper
• Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1

  2002cited by this paper
• DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.

  2002cited by this paper
• Mouse models of neurofibromatosis 1 and 2.

  2002cited by this paper
• PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum.

  2002cited by this paper
• Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment

  2002cited by this paper
• Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland.

  2002cited by this paper
• Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors

  2002cited by this paper
• Mouse models for human DNA mismatch-repair gene defects.

  2002cited by this paper
• Cyclooxygenase 2- and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps

  2002cited by this paper
• Role of Lkb1, the causative gene of Peutz–Jegher's syndrome, in embryogenesis and polyposis

  2002cited by this paper
• Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.

  2002cited by this paper
• The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans

  2002cited by this paper
• A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

  2002cited by this paper
• Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.

  2002cited by this paper
• Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene.

  2002cited by this paper
• Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2

  2002cited by this paper
• Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice

  2001cited by this paper
• Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice

  2001cited by this paper
• Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

  2001cited by this paper
• Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

  2001cited by this paper
• A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

  2001cited by this paper
• Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

  2001cited by this paper
• Animal models of tumor-suppressor genes.

  2001cited by this paper
• Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes.

  2001cited by this paper
• Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease

  2001cited by this paper
• Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9.

  2001cited by this paper
• Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice

  2001cited by this paper
• Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype.

  2001cited by this paper
• Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice

  2000cited by this paper
• The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression.

  2000cited by this paper
• Histological Grading in Ductal Carcinoma in Situ of the Breast

  2000cited by this paper
• MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability

  2000cited by this paper
• Cancer predisposition caused by elevated mitotic recombination in Bloom mice

  2000cited by this paper
• Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma

  2000cited by this paper
• Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome.

  2000cited by this paper
• Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.

  2000cited by this paper
• An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers

  2000cited by this paper
• [Peutz-Jeghers syndrome].

  2000cited by this paper
• Long‐term treatment with sulindac in familial adenomatous polyposis: Is there an actual efficacy in prevention of rectal cancer?

  2000cited by this paper
• Mutations in the WRN Gene in Mice Accelerate Mortality in a p53-Null Background

  2000cited by this paper

• Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes

  2024cites this paper
• Genetically engineered mouse models for hereditary cancer syndromes

  2023cites this paper
• PMS2-associated Lynch syndrome: Past, present and future

  2023cites this paper
• Chemoprevention for Lynch Syndrome-Associated Malignancies

  2020cites this paper
• Mismatch repair gene mutations lead to lynch syndrome colorectal cancer in rhesus macaques

  2018cites this paper
• Hereditary cancer syndromes as model systems for chemopreventive agent development.

  2016influential citation
• High-throughput transgenic mouse phenotyping using microscopic-MRI

  2012cites this paper